Home > News > Why Oligonucleotide Quality Matters
Industry Updates New Products Supplier News Upcoming Events business web

Why Oligonucleotide Quality Matters

Hits:2013   Date: 5/31/2012
Learn about the implications of efficiency in IDT’s satellite symposium at ESHG 2012
 
CORALVILLE, IA – 30 May 2012 – Integrated DNA Technologies (IDT), the world leader in oligonucleotide synthesis, will present a satellite symposium at the European Society for Human Genetics (ESHG) conference and exhibition. The talk, entitled ‘Oligonucleotides for Clinical and Research Applications’, will take place on Saturday 23rd June from 11:45 to 13:15 in the Budapest Room. IDT has pioneered the use of high-throughput quality control methods on all oligos synthesized, and data presented as part of the symposium will reveal an average coupling efficiency of over 99.5% - the best in the industry.
 
Data presented will also show how oligonucleotide quality can differ between manufacturers, which can adversely affect reaction efficiency, for example qPCR amplification and Cq values. As well as being important for obtaining reliable results, this can be a potential issue when labs are standardizing, or performing cross-lab data comparisons. IDT’s proprietary synthesis platforms have enabled the production of high quality, long oligos such as the Ultramer Oligos which, being up to 200 bases long, are ideal for cloning, mutagenesis and gene construction. In addition, the novel gBlocks Gene Fragments for use in synthetic biology are sequence verified double stranded oligos of up to 500 bases. They can be assembled into genes or longer constructs and cloned onto a plasmid vector.
 
To find out more, visit IDT at booth 228 at ESHG, Nϋrnberg Convention Centre Ost, Germany, from 23-26 June. Alternatively, please visit www.idtdna.com or follow us on twitter @idtdna for real-time updates and insights.
 
About IDT
Integrated DNA Technologies (IDT) is the largest supplier of custom nucleic acids in the United States, serving academic, government, and commercial researchers in biotechnology, clinical diagnostics, and pharmaceutical development. IDT's primary business is the manufacture of custom, synthetic DNA and RNA oligonucleotides. Today, IDT synthesizes and ships an average of 36,000 custom oligos per day to more than 86,000 customers worldwide. IDT manufacturing locations include facilities in Coralville, Iowa; San Diego, Calif.; and Leuven, Belgium. For more information visit www.idtdna.com.
 
Integrated DNA Technologies
800-328-2661 (US & Canada)
+1 319-626-8400 (outside US)